David M Schuster - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

David M Schuster

Showing results (111-120 of 173) with videos related to

Pageof 18

Sort By:

Cancer|August 9, 2025

Optimizing treatment for metastatic castration-resistant prostate cancer: Food and Drug Administration-approved therapies, emerging strategies, and biomarker-driven approachesFaisal Saeed, Jacob E Berchuck, Mehmet Asim Bilen, et al.

Advances in Radiation Oncology|August 6, 2024

Impact of Clinical Factors on 18F-Flotufolastat Detection Rates in Men With Recurrent Prostate Cancer: Exploratory Analysis of the Phase 3 SPOTLIGHT StudyBenjamin H Lowentritt, Ashesh B Jani, Brian T Helfand, et al.

Clinical Nuclear Medicine|October 17, 2018

ACR-ACNM Practice Parameter for the Performance of Fluorine-18 Fluciclovine-PET/CT for Recurrent Prostate CancerBital Savir-Baruch, Kevin P Banks, Jonathan E McConathy, et al.

The Journal of Urology|May 1, 2023

Diagnostic Performance and Safety of 18F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT)Ashesh B Jani, Gregory C Ravizzini, Benjamin A Gartrell, et al.

European Journal of Nuclear Medicine and Molecular Imaging|December 12, 2019

[18F]Fluciclovine PET/CT: joint EANM and SNMMI procedure guideline for prostate cancer imaging-version 1.0Cristina Nanni, Lucia Zanoni, Tore Bach-Gansmo, et al.

Molecular Imaging and Biology|May 19, 2009

Initial experience with the radiotracer anti-1-amino-3-[18F]Fluorocyclobutane-1-carboxylic acid (anti-[ 18F]FACBC) with PET in renal carcinomaDavid M Schuster, Jonathon A Nye, Peter T Nieh, et al.

The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|December 11, 2019

82Rubidium chloride positron emission tomography discrimination of recurrent intracranial malignancy from radiation necrosisEphraim E Parent, Ila Sethi, Jonathon Nye, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 13, 2024

Interreader and Intrareader Reproducibility of 18F-Flotufolastat Image Interpretation in Patients with Newly Diagnosed or Recurrent Prostate Cancer: Data from Two Phase 3 Prospective Multicenter StudiesPhillip H Kuo, Giuseppe Esposito, Gary A Ulaner, et al.

Clinical Nuclear Medicine|June 6, 2025

Negative 18 F-FES PET/CT Despite Estrogen Receptor Positivity by ImmunohistochemistryIsmaheel O Lawal, Xiaoxian Li, Elizabeth A Sakach, et al.

Physics in Medicine and Biology|November 22, 2021

Prostate and dominant intraprostatic lesion segmentation on PET/CT using cascaded regional-netLuke A Matkovic, Tonghe Wang, Yang Lei, et al.

Pageof 18

Search research articles

Showing results (111-120 of 173) with videos related to